Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial

被引：0
|
作者：
Kouno, T. [1 ]
Ando, M. [1 ]
Yonemori, K. [1 ]
Matsumoto, K. [1 ]
Komiyama, M. [1 ]
Okajima, E. [1 ]
Matsuoka, N. [1 ]
Fujimoto, H. [1 ]
Fujiwara, Y. [1 ]
机构：
[1] Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [11] Phase II trial of atezolizumab plus carboplatin and paclitaxel in patients with metastatic or recurrent thymic carcinoma: Marble study
    Mimori, T.
    Shukuya, T.
    Goto, Y.
    Asao, T.
    Takayama, K.
    Kaira, K.
    Tanaka, H.
    Ko, R.
    Tsubata, Y.
    Tachihara, M.
    Suzuki, T.
    Tanizaki, J.
    Sugawara, S.
    Zenke, Y.
    Shirai, Y.
    Hayashi, T.
    Mori, K.
    Takahashi, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1631 - S1632
  • [12] A randomized, phase II trial of weekly paclitaxel versus weekly paclitaxel plus carboplatin for first-line metastatic breast cancer.
    Robert, N
    Loesch, D
    Lindquist, D
    Ratnam, S
    Hyman, W
    Whittaker, T
    Logie, K
    Kruger, S
    Pippen, J
    Liu, L
    Goldstein, L
    Asmar, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S129 - S129
  • [13] Phase I trial of paclitaxel/carboplatin in advanced carcinoma of the urothelium
    Vaughn, DJ
    Malkowicz, SB
    Zoltick, B
    Ramchandani, P
    Tonkonow, B
    Armstead, B
    Wein, A
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S47 - S50
  • [14] A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Fury, Matthew G.
    Xiao, Han
    Baxi, Shrujal S.
    Sherman, Eric Jeffrey
    Smith-Marrone, Stephanie
    Ho, Alan Loh
    Sima, Camelia S.
    Nwankwo, Obiageli Ginka
    Haque, Sofia
    Katabi, Nora
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [15] Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: A phase II Hoosier Oncology Group Study
    Li, JX
    Juliar, B
    Yiannoutsos, C
    Ansari, R
    Fox, E
    Fisch, MJ
    Einhorn, LH
    Sweeney, CJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1185 - 1191
  • [16] Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
    Tan, EH
    Khoo, KS
    Wee, J
    Fong, KW
    Lee, KS
    Lee, KM
    Chua, ET
    Tan, T
    Khoo-Tan, HS
    Yang, TL
    Au, E
    Tao, M
    Ong, YK
    Chua, EJ
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 235 - 237
  • [17] Phase II Trial of Dasatinib in Combination With Weekly Paclitaxel for Patients with Metastatic Breast Carcinoma
    Morris, P. G.
    Lake, D.
    McArthur, H. L.
    Gilewski, T.
    Dang, C.
    Chaim, J.
    Patl, S.
    Lim, K.
    Norton, L.
    Hudis, C. A.
    Fornier, M. N.
    CANCER RESEARCH, 2012, 72
  • [18] A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H
    Lehmann, J
    Gravis, G
    Joensuu, H
    Bihn, B
    Geertsen, P
    Gough, J
    Chen, ZJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 400S - 400S
  • [19] A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
    Yi Xia
    Yun-hai Li
    Yun Chen
    Qi Liu
    Jun-hua Zhang
    Jia-ying Deng
    Ta-shan Ai
    Han-ting Zhu
    Harun Badakhshi
    Kuai-Le Zhao
    International Journal of Clinical Oncology, 2018, 23 : 458 - 465
  • [20] A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
    Xia, Yi
    Li, Yun-hai
    Chen, Yun
    Liu, Qi
    Zhang, Jun-hua
    Deng, Jia-ying
    Ai, Ta-shan
    Zhu, Han-ting
    Badakhshi, Harun
    Zhao, Kuai-Le
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 458 - 465
12345